{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:17:30Z","timestamp":1793132250987,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Muscular Dystrophy Western Australia"},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Save Our Sons Duchenne Foundation"},{"name":"Duchenne UK"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240317","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:01:49Z","timestamp":1602180109000},"page":"e0240317","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-5373","authenticated-orcid":true,"given":"Jessica R.","family":"Terrill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Al-Mshhdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa N.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D.","family":"Wingate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo P.","family":"Baustista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Bettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Balog-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe N.","family":"Kornegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Nghiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda D.","family":"Grounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"1","key":"pone.0240317.ref001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.","volume":"9","author":"K Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"9307","key":"pone.0240317.ref002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"AE Emery","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"pone.0240317.ref003","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00018-008-7574-8","article-title":"Two-tiered hypotheses for Duchenne muscular dystrophy","volume":"65","author":"MD Grounds","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"pone.0240317.ref004","doi-asserted-by":"crossref","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in Duchenne muscular dystrophy","volume":"2014","author":"Y Kharraz","year":"2014","journal-title":"Biomed Res Int"},{"issue":"10","key":"pone.0240317.ref005","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne Muscular Dystrophy: From Diagnosis to Therapy.","volume":"20","author":"MS Falzarano","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"pone.0240317.ref006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1542\/pir.27-3-83","article-title":"Duchenne muscular dystrophy.","volume":"27","author":"WD Biggar","year":"2006","journal-title":"Pediatr Rev."},{"issue":"1","key":"pone.0240317.ref007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy","volume":"96","author":"DG Allen","year":"2016","journal-title":"Physiol Rev"},{"issue":"4","key":"pone.0240317.ref008","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCO.0b013e328302f3fe","article-title":"Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions.","volume":"11","author":"PG Arthur","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"pone.0240317.ref009","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/cphy.c170052","article-title":"Immunobiology of Inherited Muscular Dystrophies.","volume":"8","author":"JG Tidball","year":"2018","journal-title":"Compr Physiol"},{"issue":"1","key":"pone.0240317.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10974-012-9330-9","article-title":"Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy","volume":"34","author":"JH Kim","year":"2013","journal-title":"J Muscle Res Cell Motil"},{"key":"pone.0240317.ref011","first-page":"181","article-title":"Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid","author":"CC Winterbourn","year":"2002","journal-title":"Toxicology"},{"issue":"13","key":"pone.0240317.ref012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/ars.2020.8030","article-title":"The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease.","volume":"32","author":"MJ Davies","year":"2020","journal-title":"Antioxidants & Redox Signaling."},{"key":"pone.0240317.ref013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.redox.2016.08.016","article-title":"Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.","volume":"9","author":"JR Terrill","year":"2016","journal-title":"Redox Biol."},{"issue":"11","key":"pone.0240317.ref014","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/JP271418","article-title":"Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"594","author":"JR Terrill","year":"2016","journal-title":"J Physiol"},{"key":"pone.0240317.ref015","first-page":"458","article-title":"Impact of growth on properties of sarcolemma of skeletal myofibres: Clinical and scientific implications","volume":"33","author":"M Grounds","year":"2011","journal-title":"Bioessays"},{"issue":"17","key":"pone.0240317.ref016","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy.","volume":"280","author":"TA Partridge","year":"2013","journal-title":"FEBS J."},{"issue":"1\u20132","key":"pone.0240317.ref017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00335-011-9382-y","article-title":"Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies","volume":"23","author":"JN Kornegay","year":"2012","journal-title":"Mamm Genome"},{"issue":"4","key":"pone.0240317.ref018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1471-4914(03)00031-5","article-title":"Protein carbonylation in human diseases","volume":"9","author":"I Dalle-Donne","year":"2003","journal-title":"Trends Mol Med"},{"issue":"3\u20134","key":"pone.0240317.ref019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00726-003-0011-2","article-title":"Free radical-mediated oxidation of free amino acids and amino acid residues in proteins","volume":"25","author":"ER Stadtman","year":"2003","journal-title":"Amino Acids"},{"issue":"2","key":"pone.0240317.ref020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","article-title":"Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?","volume":"142","author":"B Halliwell","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"9","key":"pone.0240317.ref021","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3109\/10715762.2011.590136","article-title":"Screening for increased protein thiol oxidation in oxidatively stressed muscle tissue","volume":"45","author":"AF El-Shafey","year":"2011","journal-title":"Free Radic Res"},{"issue":"17","key":"pone.0240317.ref022","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1111\/febs.12142","article-title":"Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.","volume":"280","author":"JR Terrill","year":"2013","journal-title":"FEBS J"},{"issue":"4","key":"pone.0240317.ref023","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11064-011-0683-z","article-title":"Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism","volume":"37","author":"R Renjini","year":"2012","journal-title":"Neurochem Res"},{"issue":"1","key":"pone.0240317.ref024","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001756-199612200-00070","article-title":"Oxidative damage to muscle protein in Duchenne muscular dystrophy","volume":"8","author":"JW Haycock","year":"1996","journal-title":"Neuroreport"},{"issue":"10","key":"pone.0240317.ref025","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1074\/mcp.R600004-MCP200","article-title":"Discovery of urinary biomarkers","volume":"5","author":"T Pisitkun","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"pone.0240317.ref026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"J Rouillon","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"pone.0240317.ref027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2017.11.024","article-title":"Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients","volume":"476","author":"H Awano","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"7","key":"pone.0240317.ref028","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2017.05.009","article-title":"Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents","volume":"27","author":"AS Robertson","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"pone.0240317.ref029","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2362.2003.01202.x","article-title":"Super-marathon race increases serum and urinary nitrotyrosine and carbonyl levels","volume":"33","author":"Z Radak","year":"2003","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"pone.0240317.ref030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.freeradbiomed.2007.05.022","article-title":"Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis","volume":"43","author":"K Margonis","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"pone.0240317.ref031","doi-asserted-by":"crossref","first-page":"F863","DOI":"10.1152\/ajprenal.00385.2002","article-title":"Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade","volume":"284","author":"R. Agarwal","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"pone.0240317.ref032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/abio.1998.2799","article-title":"Identification of oxidized proteins based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunochemical detection, isoelectric focusing, and microsequencing","volume":"263","author":"LJ Yan","year":"1998","journal-title":"Anal Biochem"},{"issue":"1","key":"pone.0240317.ref033","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/abbi.2000.1744","article-title":"Comparison of mono- and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid modified proteins","volume":"377","author":"AL Chapman","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"pone.0240317.ref034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0891-5849(00)00204-5","article-title":"Biomarkers of myeloperoxidase-derived hypochlorous acid","volume":"29","author":"CC Winterbourn","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"pone.0240317.ref035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2004.09.013","article-title":"Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine","volume":"38","author":"Y Kato","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"pone.0240317.ref036","first-page":"698","article-title":"Detection of Modified Tyrosines as an Inflammation Marker in a Photo\u2010aged Skin Model","volume":"83","author":"Y Ishitsuka","year":"2007","journal-title":"Photochem Photobiol"},{"issue":"6","key":"pone.0240317.ref037","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.2337\/db14-1001","article-title":"Hypohalous acids contribute to renal extracellular matrix damage in experimental diabetes","volume":"64","author":"KL Brown","year":"2015","journal-title":"Diabetes"},{"issue":"2","key":"pone.0240317.ref038","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3164\/jcbn.10-93","article-title":"Identification of dihalogenated proteins in rat intestinal mucosa injured by indomethacin","volume":"48","author":"T Takagi","year":"2011","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"pone.0240317.ref039","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s11307-018-1174-2","article-title":"Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.","volume":"20","author":"SM Schneider","year":"2018","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"pone.0240317.ref040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis.","volume":"9","author":"CA Schneider","year":"2012","journal-title":"Nat Methods."},{"issue":"2","key":"pone.0240317.ref041","doi-asserted-by":"crossref","first-page":"F265","DOI":"10.1152\/ajprenal.00318.2004","article-title":"On the nature of proteinuria with acute renal injury in patients with chronic kidney disease","volume":"288","author":"R. Agarwal","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"pone.0240317.ref042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nmd.2007.07.006","article-title":"Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy","volume":"18","author":"P Garrood","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"pone.0240317.ref043","first-page":"R128","article-title":"Oxidized amino acids in the urine of aging rats: potential markers for assessing oxidative stress in vivo","volume":"276","author":"C Leeuwenburgh","year":"1999","journal-title":"Am J Physiol"},{"issue":"1","key":"pone.0240317.ref044","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3164\/jcbn.08-185","article-title":"Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography\/Tandem Mass Spectrometry","volume":"44","author":"Y Kato","year":"2009","journal-title":"J Clin Biochem Nutr"},{"issue":"12","key":"pone.0240317.ref045","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.bbagen.2013.04.017","article-title":"Oxidized albumin. The long way of a protein of uncertain function","volume":"1830","author":"M Bruschi","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"7\u20138","key":"pone.0240317.ref046","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/prca.200780145","article-title":"Analysis of molecular forms of albumin in urine","volume":"2","author":"GL Hortin","year":"2008","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"pone.0240317.ref047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0003-9861(80)90101-0","article-title":"Direct demonstration of the highly reactive tyrosine residue of human serum albumin located in fragment 299\u2013585","volume":"205","author":"KJ Fehske","year":"1980","journal-title":"Arch Biochem Biophys"},{"issue":"6864","key":"pone.0240317.ref048","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/414631a","article-title":"Individual recognition in mice mediated by major urinary proteins","volume":"414","author":"JL Hurst","year":"2001","journal-title":"Nature"},{"issue":"2","key":"pone.0240317.ref049","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.taap.2013.06.018","article-title":"Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate","volume":"272","author":"N Kolisetty","year":"2013","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T18:03:35Z","timestamp":1602180215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240317"}},"subtitle":[],"editor":[{"given":"Hyojung","family":"Choo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240317","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}